Dr. Ulrickson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2940 E Banner Gateway Dr
Ste 450
Gilbert, AZ 85234Phone+1 480-256-6444Fax+1 480-256-3359
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2010 - 2013
Massachusetts General HospitalResidency, Internal Medicine, 2007 - 2010
McGovern Medical School at UTHealthClass of 2007
Certifications & Licensure
AZ State Medical License 2013 - 2027
CO State Medical License 2021 - 2023
WA State Medical License 2010 - 2014- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Enasidenib in relapsed aggressive systemic mastocytosis with IDH2 mutation.Alejandro Del Rio Verduzco, Ali Al Darobi, Alex Heimbigner, Hayley Heers, Matthew Ulrickson
Leukemia & Lymphoma. 2024-10-22 - Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil, John Tamaresis, Armin Ghobadi
Journal of Clinical Oncology. 2024-10-20 - 1 citationsAutologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh
Blood Cancer Journal. 2024-07-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
